单克隆药物治疗癌症的不良反应

Q4 Medicine

Adverse Drug Reaction Bulletin Pub Date : 2012-12-01 DOI:10.1097/FAD.0b013e32835ccbf1

Christopher M. Jones, J. Pascoe, J. Coleman

引用次数: 0

摘要

单克隆药物已被开发用于特异性靶向癌细胞，但它们可能具有危及生命的全身不良反应，特别是输注反应、免疫抑制、肿瘤溶解综合征、深度高血压、心力衰竭和血液毒性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Adverse reactions to monoclonal agents used in the treatment of cancer

SummaryMonoclonal agents have been developed to specifically target cancer cells but they can have systemic adverse effects which can be life-threatening, particularly infusion reactions, immunosuppression, tumour lysis syndrome, profound hypertension, cardiac failure and haematological toxicity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Adverse Drug Reaction Bulletin Medicine-Pharmacology (medical)

CiteScore

0.70

自引率

0.00%

发文量

期刊介绍： For over 40 years, Adverse Drug Reaction Bulletin has provided comprehensive coverage in the field of adverse drug reactions. Each issue contains an invited article on a topic of current interest, dealing with specific conditions from drug-induced lung disorders to drug-induced sexual dysfunction, or types of drugs from lipid-lowering agents to poisons antidotes. This bimonthly journal"s articles are timely, succinct and fully referenced